ArticleJournal of veterinary internal medicine2021
Evaluation of antimicrobial prescriptions in dogs with suspected bacterial urinary tract disease.
Article in Journal of veterinary internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.
- Short versus longer duration antibiotic treatment for urinary tract infections in companion animals: a systematic review and meta-analysis.BMC veterinary research · 2025Pooled it
- Chilean Honey as Alternative Antibacterial: In Vitro Activity Against Multidrug-Resistant Canine Bacterial Pathogens.Animals : an open access journal from MDPI · 2026Article
- Enrofloxacin-associated ocular disease in cats: A scoping review.The Canadian veterinary journal = La revue veterinaire canadienne · 2025Article
- Antimicrobial use in animals: When more might be better.The Canadian veterinary journal = La revue veterinaire canadienne · 2025Article
- Antimicrobial Resistance in Companion Animals: A 30-Month Analysis on Clinical Isolates from Urinary Tract Infections in a Veterinary Hospital.Animals : an open access journal from MDPI · 2025Article
- Mitigating antimicrobial resistance, an approach to stewardship in canine urinary tract infection.Veterinary research communications · 2024Article
- Genotypic Characterization of UropathogenicAntibiotics (Basel, Switzerland) · 2023Article
- Prevalence and Antimicrobial Resistance of Bacterial Uropathogens Isolated from Dogs and Cats.Antibiotics (Basel, Switzerland) · 2022Article
- Estimation of defined daily doses of antimicrobials for dogs and cats treated for bacterial cystitis.The Canadian veterinary journal = La revue veterinaire canadienne · 2022Article
- Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs.Frontiers in veterinary science · 2022Article
- Evaluation of antimicrobial prescriptions in dogs with suspected bacterial urinary tract disease.Journal of veterinary internal medicine · 2021Article
- Antimicrobial susceptibility patterns from urinary isolates obtained from cats (2013-2020).Journal of veterinary internal medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntimicrobials are commonly used to treat urinary tract disease in dogs. Understanding antimicrobial use is a critical component of antimicrobial stewardship efforts. HYPOTHESIS/
objectivesTo evaluate antimicrobial prescriptions for dogs diagnosed with acute cystitis, recurrent cystitis, and pyelonephritis. ANIMALS: Dogs prescribed antimicrobials for urinary tract disease at veterinary practices in the United States and Canada. MATERIALS AND
methodsA retrospective review of antimicrobial prescriptions was performed.
resultsThe main clinical concerns were sporadic bacterial cystitis (n = 6582), recurrent cystitis (n = 428), and pyelonephritis (n = 326). Amoxicillin/clavulanic acid (2702, 41%), cefpodoxime (1024, 16%), and amoxicillin (874, 13%) were most commonly prescribed for sporadic bacterial cystitis. The median prescribed duration was 12 days (range, 3-60 days; interquartile range [IQR], 4 days). Shorter durations were used in 2018 (median, 10 days; IQR, 4 days) compared to both 2016 and 2017 (both median, 14 days; IQR, 4 days; P ≤ .0002). Amoxicillin/clavulanic acid (146, 33%), marbofloxacin (95, 21%), and cefpodoxime (65, 14%) were most commonly used for recurrent cystitis; median duration of 14 days (range, 3-77 days; IQR, 10.5 days). Amoxicillin/clavulanic acid (86, 26%), marbofloxacin (56, 17%), and enrofloxacin (36, 11%) were most commonly prescribed for pyelonephritis; however, 93 (29%) dogs received drug combinations. The median duration of treatment was 14 days (range, 3-77 days; IQR, 11 days). CONCLUSIONS AND CLINICAL IMPORTANCE: Decreases in duration and increased use of recommended first-line antimicrobials were encouraging. Common drug choices and durations should still be targets for antimicrobial stewardship programs that aim to optimize antimicrobial use, concurrently maximizing patient benefits while minimizing antimicrobial use and use of higher tier antimicrobials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.